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Abstract 
Background 
Studies have reported that Cognitive Behavioural Therapy (CBT) and Graded Exercise Therapy 
(GET) are effective treatments for Chronic Fatigue Syndrome (CFS).  
Method 
One hundred and seventy one patients undertook a course of either CBT (n=116) or GET (n=55) 
and where assessed on a variety of self-report measures at pre- and post-treatment and follow-up. 
Aim 
In this paper we present analyses on treatment outcomes for CBT and GET in routine clinical 
practice and evaluate whether changes on subscales of the Metacognitions Questionnaire-30 (MCQ-
30) predict fatigue severity independently of changes in other covariates, and across the two 
treatment modalities. 
Results 
Both CBT and GET were equally effective at decreasing fatigue, anxiety, and depression, and at 
increasing physical functioning. Changes on the subscales of the MCQ-30 were also found to have a 
significant effect on fatigue severity independently of changes in other covariates and across 
treatment modalities. 
Conclusion 
The findings from the current study suggest that CFS treatment protocols for CBT and GET, based 
on those from the PACE trial, achieve similar-to-poorer outcomes in routine clinical practice as in a 
RCTs 
 
 
 
Key words: cognitive behavioural therapy; chronic fatigue syndrome; graded exercise therapy; 
metacognitions; metacognitive change; outcomes evaluation. 
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1. Introduction 
Chronic Fatigue Syndrome (CFS) is a complex condition involving both biological and 
psychological dimensions. The constellation of symptoms that result from this condition have a 
wide range of detrimental impacts on an individual’s quality of life. No specific test, or any physical 
sign for the diagnosis of CFS, exists. CFS is a diagnosis of exclusion: it is made when it is has not 
been possible to attribute a patient’s symptoms to any other known disease process. CFS is 
characterised by the presence of a severe and disabling fatigue, both physical and mental, for at 
least 6 months, that is not life-long but has a definite onset (Sharpe et al., 1991). Currently, no 
aetiology for CFS has been identified, thus it can be considered part of the spectrum of Medically 
Unexplained Symptoms. In terms of treatment, the National Institute for Health and Clinical 
Excellence (NICE, 2007) recommends Cognitive Behavioural Therapy (CBT) and Graded Exercise 
Therapy (GET) for CFS/ME (Myalgic Encephalomyelitis), as well as suggesting pacing for the 
severely affected.  
1.1. CBT and GET for CFS 
The CBT model of CFS attends to factors that may predispose (e.g. perfectionism), 
precipitate (e.g. virus, stress, and/or trauma), and perpetuate (e.g. stress, negative emotion, and all-
or-nothing patterns of behaviour) symptoms. This model models incorporate fear-avoidance beliefs 
as a maintaining factor, driving all-or-nothing patterns of behaviour, contributing emotional distress 
and exacerbating symptom severity. Fear-avoidance beliefs are sometimes controversial, with some 
patient groups believing that they are ‘victim-blaming’. However, research has suggested that 
changes in avoidance behaviour and related beliefs are associated with good outcome in CBT 
(Deale, Chalder, & Wessely, 1998). 
The GET model of CFS is based on the concept of de-conditioning. After encountering an 
initial trigger to CFS (such as a viral infection), maladaptive coping responses (e.g. resting to get 
better) lead to de-conditioning. GET encourages patients to establish an ‘exercise baseline’ (a 
duration of exercise that does not significantly exacerbate symptoms) and to gradually increase first 
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it’s duration and then the intensity. Research suggests that the GET mechanism of change is through 
the modification of interpretations about bodily sensations (Moss-Morris, Sharon, Tobin, & Baldi, 
2005).  
Several RCTs have found evidence to suggest both CBT and GET are effective treatments 
for CFS (e.g. Moss-Morris et al., 2005; Prins et al., 2001). Recently a large multi-centred RCT 
compared CBT, GET and Adaptive Pacing Therapy (APT) with specialist medical care (SMC) to 
SMC alone (White et al., 2011) and found both GET and CBT to be moderately effective treatments 
for CFS. Non-significant differences were found between APT and SMC alone. However, the 
results of a RCT may be a consequence of the context in which they occur and may differ in routine 
clinical practice. Indeed, outcomes in RCTs for CFS have been found to be superior to those 
achieved in routine clinical practice (Quarmby, Rimes, Deale, Wessely, & Chalder, 2007). 
1.2. The Role of Metacognitions in CFS 
Research indicates that CBT and GET are beneficial, however limited efforts have been 
focused on examining the effects of such treatment modalities on specific cognitive processes that 
are hypothesized to mediate change. Such studies are helpful to identify target treatments, consider 
suitability, and explore mechanisms of change. 
The Self-Regulatory Executive Function (S-REF) model (Wells, 2011) suggests that 
vulnerability to, and maintenance of, psychological problems is associated with a cognitive-
attentional syndrome (CAS) characterized by perseverative thinking (e.g. rumination and worry), 
threat monitoring, and self-regulation strategies that fail to modify maladaptive self-knowledge. The 
CAS is driven by metacognitions, which are beliefs that specify the execution of ruminative/worry 
processing, guide attention, and serve as a resource for interpreting and controlling cognitive events 
such as unwanted thoughts. A wide evidence base supports the relationship between 
metacognitions, aspects of the CAS, and a range of negative emotional outcomes and psychological 
problems (for a review see Wells, 2011).  
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Recent studies have provided support for CAS configurations in CFS. For example, 
interpretative biases for processing somatic information (Moss-Morris & Petrie, 2003), high levels 
of self-reported health-related worry and preoccupation with health threats (Aggarwal, McBeth, 
Zakrzewska, Lunt, & Macfarlane, 2006), together with attentional biases for processing health-
threat information (Hou, Moss-Morris, Bradley, Peveler, & Mogg, 2008), have been found to be 
present in CFS patients. For a review of these cognitive processes see Knoop, Prins, Moss-Morris, 
and Bleijenberg (2010). 
Other studies have posited a role for metacognitions in CFS. Specifically, metacognitions 
regarding lack of cognitive confidence and need to control thoughts have been found to predict CFS 
symptom severity when controlling for negative emotion (Maher-Edwards, Fernie, Murphy, Wells, 
& Spada, 2011). Metacognitions pertaining to the need to control thoughts may lead to the 
activation of effortful and maladaptive coping strategies (e.g. thought suppression, worry, and 
rumination) that may increase fatigue and negative appraisals of cognitive experiences. 
Metacognitions regarding a lack of cognitive confidence may limit choice and inhibit activation of 
adaptive coping strategies when feeling fatigued. Additionally, metacognitions pertaining to 
perserverative conceptual thinking about symptoms and body-focussed attention were elicited from 
individuals with CFS (Maher-Edwards, Fernie, Murphy, Nikcevic, & Spada, 2012). 
1.3. Aims of the Current Study 
The aims of the current study were to analyse outcomes for both CBT and GET for CFS in 
routine clinical practice (i.e. within a specialist fatigue service) as well as to examine metacognitive 
change as a predictor of treatment outcome. The central hypothesis tested was that reductions in 
metacognitions occurring within treatment for CFS would be associated with improvements in 
fatigue severity independently of changes in other covariates, and across the two therapeutic 
modalities.  
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2. Method 
2.1. Patients 
One hundred and seventy one patients began a course of either CBT (n=116) or GET (n=55) 
at the Fatigue Service at the Royal Free Hospital, London, UK, between the 12thApril 2010 and the 
4th March 2013. They provided signed consent for their data to be used in a service evaluation. Of 
the 171 patients who started therapy, 148 completed therapy (103 CBT and 45 GET patients), 
representing 86.5% completion rate, attending a mean of 13.7 (CBT) and 13.4 (GET) sessions. 10 
CBT patients and seven GET dropped out of therapy without agreeing to do so first with their 
therapist. Three patients each from CBT and GET ended therapy with the consent of their therapist. 
The mean age of patients was 40.8 years (SD=12.5; range 18-75). Patients with a diagnosis of CFS 
according to the Oxford Criteria (Sharpe et al., 1991) were included in this study. Table 1 shows 
fatigue, physical functioning, anxiety, and depression baseline scores for CBT and GET patients. 
2.2. Self-report Measures 
Chalder Fatigue Questionnaire [CFQ (Chalder et al., 1993)] 
The CFQ is an 11-item self-report measure that assesses levels of mental (e.g. “Do you need 
to rest more?”) and physical (e.g. Do you have problems with tiredness?”) fatigue over the previous 
month. The measure employs a four-point Likert-type response format to which respondents are 
required to indicate the extent the severity of their different symptoms compared to ‘usual’. Higher 
scores indicate higher levels of mental and physical fatigue. The CFQ can be scored in two ways: 
(1) using a bimodal system (0, 0, 1, 1), with a possible range of 0-11; or (2) using system where 
each possible response is assigned either 0, 1, 2 or 3 point value, producing a possible range of 0-
33. This study utilises the four-point scoring system. The CFQ possesses good psychometric 
properties (Chalder et al., 1993) and is recommended for use in the Adult Minimum Dataset for 
assessing severity of CFS/ME (NICE, 2007). 
 
 
CBT and GET for Chronic Fatigue Syndrome                                                                                                 March  2015 
 
 7 
RAND Short Form 36 Physical Functioning [SF-36 PF (Ware Jr & Sherbourne, 1992)] 
The SF-36 PF is a 10-item self-report measure assessing daily activities such as climbing 
stairs, lifting or carrying groceries, walking, and bathing. It is the Physical Functioning subscale of 
the RAND Short Form 36 Health Questionnaire that assesses function in different areas such as 
general health, social functioning, mental health and limitations in role activities because of 
physical or emotional problems (Ware Jr & Sherbourne, 1992). Participants indicate how much 
their health limits them in these activities, responding to individual items by choosing between “a 
lot”, “a little” or “not at all”. Higher scores indicate higher levels of physical functioning. The SF-
36 PF is a widely used, reliable, and valid measure with population norms and normative data for a 
variety of medical conditions (Ware & Kosinski, 2001).  
Hospital Anxiety and Depression Scale [HADS (Zigmond & Snaith, 1983)] 
The HADS is a 14-item self-report measure that assesses anxiety and depression. The 
anxiety factor (7 items) consists of items like “I get a sort of frightened feeling as if something 
horrible is about to happen”. The depression factor (7 items) consists of items like “I feel as if I am 
slowed down”. Higher scores indicate higher levels of anxiety and depression. The HADS 
possesses good psychometric properties (Mykletun, 2001; Zigmond & Snaith, 1983). 
Metacognitions Questionnaire 30 [MCQ-30 (Wells & Cartwright-Hatton, 2004)] 
The MCQ-30 is a 30-item self-report measure that assesses five-factors pertaining to 
metacognition: (1) positive beliefs about worry (e.g. “Worrying helps me cope”); (2) negative 
beliefs about thoughts concerning uncontrollability and danger (e.g. “When I start worrying I 
cannot stop”); (3) cognitive confidence (e.g. “My memory can mislead me at times”); (4) beliefs 
about the need to control thoughts (e.g. “Not being able to control my thoughts is a sign of 
weakness”); and (5) cognitive self-consciousness (e.g. “I pay close attention to the way my mind 
works”). Respondents are required to indicate the extent of their agreement with the metacognitions 
presented on a four-point Likert-type answer system. Higher scores indicate higher levels of 
unhelpful metacognitions. The MCQ-30 possesses good psychometric properties (Spada, 
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Mohiyeddini, & Wells, 2008; Wells & Cartwright-Hatton, 2004). Reliability analysis on MCQ-30 
responses from this sample indicates that it possesses good-to-excellent internal consistency (i.e. 
Cronbach’s alphas for each of the five factors were .89, .91, .92, .83, and .87 respectively). These 
are similar Cronbach’s alphas to those obtained by Maher-Edwards et al. (2011). 
Clinical Global Impression [CGI (Guy, 1976)] 
 This is a single item self-report measure that assesses change in the severity of fatigue 
symptoms over the previous 3 months on a seven-point Likert scale (‘very much better’, ‘much 
better’ ‘a little better’, ‘no change’, ‘a little worse’, ‘much worse’ and ‘very much worse’). 
Therapy Satisfaction Scale [TSS] 
 This is a single item self-report measure that assesses satisfaction with therapy on a seven-
point Likert scale (‘very satisfied’, ‘satisfied’, ‘a little satisfied’, ‘neither satisfied nor dissatisfied’, 
‘a little dissatisfied’, ‘dissatisfied’ and ‘very dissatisfied’). 
2.3. Procedure and Care Pathway 
 Patients were referred to the service via their GP and then assessed by the team physician for 
a CFS diagnosis. Patients interested in therapy were offered a further assessment conducted by a 
team therapist. Patient preference drove choice of therapy, and this decision would be confirmed 
during the clinical team’s weekly multidisciplinary meeting. Following assessment patients were 
given the pre-treatment self-report measures booklet. Patients were then contacted either by 
telephone or mail to arrange their first session of therapy.   
14 sessions of either CBT or GET were administered. The first 12 of these sessions were 
typically weekly or fortnightly. Following session 12 patients completed the post-treatment self-
report measures booklet. Sessions 13 or 14 were follow-up or booster sessions, typically occurring 
at four to eight week intervals after session 12.  Patients completed their follow-up self-report 
measures booklet at or shortly after session 14. On treatment completion, a physician or clinical 
nurse specialist conducted a medical review. 
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 Following the submission of a brief proposal and consultation with the Research and 
Development team at the hospital, this study was deemed a service evaluation and therefore did not 
need to obtain ethics approval. 
2.4. CBT and GET Treatment Protocols 
Both CBT and GET treatment protocols followed closely the treatment protocols used in the 
PACE trial (White et al., 2011), outlined in (White, Sharpe, Chalder, DeCesare, & Walwyn, 2007). 
CBT therapists were all qualified or trainee clinical and counselling psychologists and supervised 
by a senior psychologist (first author) who specializes in CBT. GET therapists were either 
physiologists or exercise physiologists and were supervised by a senior physiotherapist for GET-
related issues and by the first author for therapy relationship-issues. Supervision frequency was 
based on relevant professional guidelines as a minimum. Three therapists (three) had been involved 
in the PACE trial, either providing therapy or as a co-supervisor. A total of six psychologists (not 
working concurrently) contributed data to this evaluation, along with one physiotherapist and one 
exercise physiologist. 
CBT and GET shared many components including the use of activity and sleep diaries, 
activity scheduling with graded increases in activity, promotion of sleep hygiene, and relaxation 
exercises. Differences centred on GET’s focus on exercise baselines and CBT’s attention to coping 
strategies and challenging unhelpful beliefs about symptoms and activity. 
2.5. Data Analysis 
 The data analysis strategy used, where possible, mirrored that utilised by the PACE trial 
(White et al., 2011). Primary outcome variables used continuous outcomes and these measures were 
prorated by adding a mean score value for missing items if a maximum of two scores were missing. 
Difference tests were conducted on baseline primary and secondary outcome data between 
therapies. Four linear mixed-modelling regression analyses were conducted using Statistical 
Package for the Social Sciences version 20 (IBM, 2011). These had fatigue (CFQ), physical 
functioning (SF-36 PF), and both anxiety and depression (HADS) as outcome variables. The 
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variable ‘time’ was created to represent the index for repeated measurements (pre-treatment, post-
treatment, and follow-up) and was entered as a fixed effect in all models, as was treatment 
modality. Each patient was given a random slope and intercept to allow a unique growth trajectory. 
The first model generated, with fatigue as the outcome variable, had change in anxiety, depression, 
beliefs concerning uncontrollability and danger of thoughts, and cognitive confidence covariates 
entered as fixed effects. These covariates were chosen for the first model on the basis of a non-
parametric correlation matrix that explored relationships between the change in fatigue scores and 
changes in all measured variables between pre-treatment and follow-up. Several models were 
developed that controlled for negative affect and type of therapy, with different combinations of 
metacognitive covariates as fixed effects. The model presented was chosen on the basis of measures 
of model strength, power, and ease of interpretation. 
We recoded the CGI and TSS into three levels and presented these as percentages. In line 
with the PACE trial’s presentation of this data, CGI responses of ‘very much better’ and ‘much 
better’ were coded as ‘positive change’; ‘a little better’, ‘no change’ and ‘a little worse’ were coded 
as ‘minimal change’; and ‘much worse’ and ‘very much worse’ were coded as ‘negative change’. 
TSS responses of ‘very satisfied’ and ‘satisfied’ were coded as ‘satisfied’; ‘a little satisfied’, 
‘neither satisfied’ and ‘a little dissatisfied’ were coded as ‘mostly indifferent’; while ‘dissatisfied’ 
and ‘very dissatisfied’ were coded as ‘dissatisfied’.  
3. Results 
 Kolmogorov-Smirnov tests suggested that all primary and secondary outcomes were 
significantly different from normal. As result, a series of Mann-Whitney tests were conducted on 
the baseline values of these variables. These revealed a significant difference between baseline 
values of physical functioning [U=2340; p=.009] (with lower functioning in GET patients) and 
anxiety [U=2266, p=.002] (with greater anxiety on CBT patients). No significant differences were 
found between CBT and GET patients in fatigue [U=3033, p>.05] and depression [U=2844, p>.05]. 
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Table 1 shows the mean scores of the primary (CFQ and SF-36 PF) and secondary (HADS) 
outcome measures, suggesting that levels of fatigue, anxiety and depression all decreased during 
treatment and that physical functioning increased, for both CBT and GET. Table 1 also shows that 
the effect size of both treatment modalities on the four outcome variables was large. Table 2 shows 
that treatment, regardless of modality, had a significant effect on fatigue, physical functioning, 
anxiety, and depression. In addition, it shows that when the two metacognitive change covariates 
(negative beliefs about thoughts concerning uncontrollability and danger, and cognitive confidence) 
were entered into the model, along with the anxiety and depression covariates, both (together with 
depression) had significant fixed effects on levels of fatigue. The fixed effect of modality of 
treatment was significant when anxiety and physical functioning were the outcome variables. 
 Table 3 shows the CGI and TSS outcomes at post-therapy and follow-up, as well as 
clinically useful change. These suggest that the majority of patients were satisfied with their 
treatment with roughly half who completed both treatment modalities reporting a positive change. 
Very few patients reported dissatisfaction with treatment or a negative change. Clinically useful 
change was assessed using the same method adopted by the PACE trial: i.e. an improvement of two 
or more in CFS scores and/or eight or more in SF-36 PF. Table 3 presents this data for both the 
entire sample and a subsample of patients who met PACE trial inclusion criteria (i.e. six or more on 
bimodal CFS and 60 or less on the SF-36 PF) to account for restriction of range issues. 
4. Discussion 
Together with the findings of the PACE trial (White et al., 2011), this evaluation provides 
further evidence that suggests that both CBT and GET are effective treatments for CFS. The 
analyses also suggest that both treatment options decrease fatigue, anxiety, and depression, as well 
as increase physical functioning. Both treatment options also appear to be satisfactory for the 
majority of patients and the overall completion rate was good, which may be attributed to the 
therapy assessment, affording the opportunity for patients to ask questions and make informed 
treatment choices, and therapists to identify potential obstacles to therapy (NICE, 2007). The CGI 
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data is comparable to that obtained by the PACE trial (White et al., 2011) but the clinical change 
data is worse (for CBT, comparing PACE to this evaluation, it was 59% versus 50% and for GET 
61% to 34.3%). This difference seems due to treatments in this study impacting more on fatigue 
than physical functioning. It is worth noting that the end point for follow-up measures was 12 
months for the PACE trial and at or after session 14 for patients in this service, and this could 
represent as little as six months between pre-treatment and follow-up. It may be that both CBT and 
GET require sustained application of therapeutic strategies for their full benefit to be felt. 
 Treatment modality was driven by patient choice and this may explain differences in 
baseline levels of anxiety and physical functioning, and consequently the variation in outcomes 
between CBT and GET. Anxious patients may choose CBT over GET because they are more 
concerned by physical activity or because CBT seems a more ‘natural fit’ with how they prioritise 
their symptoms. Similarly, those with lower physical functioning may perceive GET as more 
appropriate for their needs. Differences in baseline levels of anxiety and physical functioning 
mirrors the difference in treatment effects between the two treatment modalities and maybe 
reflective of a ‘restriction of range’: i.e. patients with higher anxiety and lower physical functioning 
have more ‘room to improve’. 
Changes in depression, beliefs about thoughts concerning uncontrollability and danger, and 
cognitive confidence were found to produce significant effects in the regression equations when 
fatigue severity was the outcome variable, regardless of treatment modality. The relationship 
between changing levels of depression and severity of fatigue symptoms could be explained in 
several ways. For example, levels of depression may reduce as patients’ symptoms are ameliorated. 
Alternatively, CBT treatment protocols for depression and CFS may share common features, and it 
may be this overlap that, in part, explains changing levels of depression. Finally, GET uses exercise 
as a central therapeutic tool and this has been shown to reduce depression (Cooney et al., 2013).  
The relationship between fatigue levels and metacognitions is more difficult to explain. 
While it is possible that metacognitions were indirectly addressed in CBT (Wells, 2011), this is 
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unlikely to be the case in GET. Beliefs about thoughts concerning uncontrollability and danger 
might lead to negative appraisals of cognitive experiences, consequently activating perseverative 
cognitive processes such as worry and rumination. Such perseverative thinking may not only 
increase negative effect, leading to physiological changes that may alter the experience of fatigue 
and disrupt restorative sleeping patterns, but also require effort that may contribute to mental 
fatigue. Alternatively, it could be that the relationship between beliefs about thoughts concerning 
uncontrollability and danger and changes in fatigue severity might reflect reductions in worry and 
symptom preoccupation - variables that have been shown to mediate outcomes in GET (Moss-
Morris et al., 2005).  
Metacognitions about lack of cognitive confidence may reflect the cognitive difficulties 
reported by individuals with CFS. Increases in cognitive confidence may simply be a consequence 
of improved concentration and memory, resulting from reductions in fatigue. However, 
metacognitions about cognitive confidence may also result in the inhibition of adaptive coping 
strategies when fatigued. For example, individuals with low cognitive confidence may be inclined 
to worry about perceived poor cognitive performance, and this effortful cognitive process may 
contribute to the severity of mental fatigue. The failure to find a significant effect of the need to 
control thoughts in the developmental models, which would be a parallel finding to the study by 
Maher-Edwards et al. (2011), may be explain the choice of outcome variable. In the earlier study, 
the outcome variables used were the subscales of the CFQ (mental and physical) rather than the 
total fatigue score used in this study.  
Earlier research has suggested other mediators of therapeutic change in CFS. For example, it 
seems that reductions in fear-avoidance beliefs and focus on fatigue mediate change in CBT (Stahl, 
Rimes, & Chalder, 2014; Wiborg, Knoop, Prins, & Bleijenberg, 2011) and in GET (Moss-Morris et 
al., 2005). Arguably, from an MCT perspective, symptom focus may form part of the CAS because 
it is an attentional strategy potentially fuelled by metacognitions (Fernie, Maher-Edwards, Murphy, 
Nikcevic, & Spada, 2014). Recent research has suggested that change in fear-avoidance beliefs is 
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more important in GET than CBT for predicting treatment outcome (Chalder, Goldsmith, White, 
Sharpe, & Pickles, 2015), even though this is not transparently targeted in the former. While this 
implies that directly targeting a mediator (such as fear-avoidance or, possibly, metacognition) is not 
necessary for change, it does not indicate whether mediator-targeted treatment would increase the 
magnitude of change. 
This study is subject to some limitations that are unique to routine clinical practice. Firstly, 
only patients who consented for their data to be used were included in this analysis, and if they did 
not provide consent at all three data points, their data was withdrawn. Secondly, patients not 
consenting for their data to be used in such study may be reflective of dissatisfaction with treatment 
modalities offered. Thirdly, more confounding variables exist in routine clinical practice when 
compared to RCTs. For example, in routine clinical practice a wider range of patients tend to be 
seen with physical and psychiatric comorbidities, less commonly seen in patients in a RCT. Also, 
there is less control over treatment fidelity in routine clinical practice when compared to RCTs. 
Fourthly; we did not have a sufficient sample size to adequately power an analysis that modelled all 
five MCQ-30 factors and/or interaction effects, limiting an interpretation of the relative contribution 
of specific metacognitive factors to therapeutic change in CFS. Fifthly, psychiatric comorbidity was 
not fully clinically assessed and is not included in the data analysis. However, this study presents 
baseline anxiety and depression scores for both CBT and GET patients, which provides some sense 
of patients’ emotional state. Finally, condition characteristics such as symptom duration were not 
recorded in the dataset, preventing the analysis of their role. 
In conclusion, the findings from the current study suggest that CFS treatment protocols for 
CBT and GET, based on those from the PACE trial, achieve similar-to-poorer outcomes in routine 
clinical practice as in a RCTs. Both CBT and GET met with high levels of patient satisfaction, 
suggesting that such treatments are well received despite the controversy with which they are 
sometimes associated.  
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Table 1: Means, standard deviations, and effect sizes across treatment modalities for fatigue (CFQ), physical 
functioning (SF-36 PF), anxiety (HADS-A) and depression (HADS-D) 
 
          CFQ        SF-36 PF         HADS-A        HADS-D 
 CBT 
(SD) 
GET 
(SD) 
CBT 
(SD) 
GET 
(SD) 
CBT 
(SD) 
GET 
(SD) 
CBT 
(SD) 
GET 
(SD) 
Pre-treatment 22.96 
(5.74) 
22.49 
(6.22) 
61.18 
(28.96) 
51 
(25.05) 
10.18 
(4.37) 
8.26 
(4.44) 
8.21 
(4.10) 
7.66 
(4.01) 
Post-treatment 15.86 
(7.74) 
17.71 
(9.15) 
65.76 
(24.75) 
60.29 
(25.60) 
8.04 
(3.51) 
6.97 
(4.20) 
5.12 
(2.93) 
5.71 
(3.89) 
Follow-up 14.71 
(7.85) 
15.46 
(7.70) 
68.96 
(25.30) 
61.00 
(26.70) 
7.64 
(3.08) 
6.47 
(4.67) 
5.08 
(3.63) 
4.83 
(3.75) 
Effect size 
(Cohen’s d) 
.97 .83 .36 .50 .75 .61 .90 .91 
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Table 2: Estimates of fixed effects for four linear mixed model regression analyses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Estimation T P 
Outcome variable: CFQ (Fatigue)    
1. Intercept 11.21 8.82 <.001 
2. Treatment modality -.49 -.57 .57 
3. Timepoint 1  5.46 7.82 .001 
4. Timepoint 2 .80 1.09 .28 
5. Timepoint 3 - - - 
6. HADS-Anxiety 0.18 1.68 .09 
7. HADS-Depression 0.71 6.90 <.001 
8. MCQ-30-Negative Beliefs about Thoughts -0.26 -2.40 .02 
9. MCQ-30-Cognitive Confidence 0.17 1.68 <.05 
Outcome variable: SF-36 PF (Physical Functioning)    
1. Intercept 57.39 16.59 <.001 
2. Treatment modality 8.17 2.02 <.05 
3. Timepoint 1  -8.98 -5.39 <.001 
4. Timepoint 2 -2.18 -1.42 .16 
5. Timepoint 3 - - - 
Outcome variable: HADS-Anxiety    
1. Intercept 6.48 11.27 <.001 
2. Treatment modality 1.74 2.64 <.01 
3. Timepoint 1  2.13 6.65 <.001 
4. Timepoint 2 .34 1.34 .18 
5. Timepoint 3 - - - 
Outcome variable: HADS-Depression    
6. Intercept 5.60 10.50 <.001 
7. Treatment modality .01 .01 .99 
8. Timepoint 1  2.93 10.01 <.001 
9. Timepoint 2 .25 1.19 .24 
10. Timepoint 3 - - - 
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Table 3: Clinical Global Impression (CGI), Therapy Satisfaction Scale (TSS), and clinically useful change 
outcomes at post-treatment and follow-up 
 
 
 
 
  CBT (%)   GET (%) 
  CGI 
Post-Treatment 
 
Positive change 50.5 51.2 
Minimal change 49.5 47.6 
Negative change 0.0 1.2 
Follow-up 
 
Positive change 49.4 42.1 
Minimal change 48.2 50.0 
Negative change 2.4 7.9 
   TSI  
Post-Treatment 
 
Satisfied 97.7 95.4 
Mostly indifferent 2.3 2.3 
Dissatisfied 0.0 2.3 
Follow-up 
 
Satisfied 93 97.4 
Mostly indifferent 5.9 2.6 
Dissatisfied 1.1 0.0 
  Clinically useful change in fatigue (CFS) 
Post-treatment 
 
Entire sample (n=148) 62.1 62.2 
PACE inclusion criteria (n=80) 58.3 65.6 
 
Follow-up 
Entire sample 62.1 60.0 
PACE inclusion criteria 60.4 56.3 
  Clinically useful change in physical 
functioning  (SF-36 PF) 
Post-treatment 
 
Entire sample 35.0 46.7 
PACE inclusion criteria 47.9 50.0 
 
Follow-up 
Entire sample 37.9 42.2 
PACE inclusion criteria 56.3 43.8 
  Clinically useful change in fatigue and 
physical functioning 
Post-treatment 
 
Entire sample 30.1 37.8 
PACE inclusion criteria 41.7 43.8 
 
Follow-up 
Entire sample 33.0 33.3 
PACE inclusion criteria 50.0 34.4 
